We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DRG International, Inc.

DRG International, a global innovator of high-quality medical diagnostics and equipment, provides the medical and res... read more Featured Products: More products

Download Mobile App





DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer

By LabMedica International staff writers
Posted on 21 Nov 2019
Print article
Image: DRG:HYBRiD-XL (Photo courtesy of DRG Instruments GmbH)
Image: DRG:HYBRiD-XL (Photo courtesy of DRG Instruments GmbH)
DRG Instruments GmbH (Marburg, Germany) demonstrated its fully automated random access analyzer, DRG:HYBRiD-XL, along with its newest ELISAs, at this year's MEDICA, the world's largest annual medical technology trade fair, that took place from 18-21 November in Düsseldorf, Germany. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

DRG Instruments specializes in the development and production of innovative ELISAs and Chemiluminescent assays, both for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function and many more. Recently, DRG Instruments developed the world’s first nonradioactive immunoassays for the determination of active Renin and PLGF, as well as a complete panel of sensitive assays for the quantitative determination of saliva steroids. In the last five years, DRG Instruments has developed its own tumor marker panel and a broad range of ELISAS in the field of infectious diseases, including the world’s first assay for the qualitative detection of human Fasciola IgG.

At the MEDICA 2019 International Trade Fair, DRG demonstrated DRG:HYBRiD-XL, its fully automated, continuous access analyzer that allows the simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests, in one sample. It allows medical practitioners to carry out up to 40 tests of different types or 40 times of the same test, or up to 20-patient samples over a wide range of pre-packaged tests to serve different specialties.

Additionally, DRG presented several new DRG ELISAs, including Bordetella pertussis Toxin IgA/IgG (quantitative), Aspergillus fumigatus IgG/IgM and Bartonella Ab, at the event. The company also displayed its new and optimized SALIVA ELISAs: Unique Salivary Hepcidin and optimized Salivary Estradiol. The company’s saliva diagnostics products offer several benefits such as non-invasive sampling, measurement of the free (unbounded) fraction of steroids, and much higher diagnostic relevance with reproducible and reliable results, compared to serum analytics.

Related Links:
DRG Instruments GmbH

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Molecular Diagnostics

view channel
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)

Smartphone-Controlled Microfluidic Device Enables Rapid Influenza Detection

The influenza virus represents a significant public health concern, annually causing epidemics with high morbidity and mortality rates. The virus is known for its high mutation rate and the existence of... Read more

Hematology

view channel
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more

Pathology

view channel
Image: High-speed brightfield scanners offer excellent image quality to aid pathologists\' review of digital slides (Photo courtesy of Roche)

Whole-Slide Imaging System Enables Pathologists to Diagnose Patients Using Digital Images

Digital pathology involves the digitalization of the traditional pathology workflow, starting from slide scanning to visualization, to analysis. Digital pathology is transforming traditional histopathology... Read more

Industry

view channel
Image: The global urinalysis market is projected to grow at a CAGR of 9.6% to USD 6.8 billion by 2029 (Photo courtesy of Shutterstock)

Global Urinalysis Market Driven by Technological Advancements in POC Testing

Urinalysis is a practical and efficient technique for analyzing urine samples to detect various infections and chronic diseases such as diabetes, urinary tract infections, and kidney disease.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.